Search Results
Results found for "richard leduc"
- GPCR Retreat Committee 2023 | Dr. GPCR Ecosystem
Richard Leduc Dr. Yamina Berchiche Dr. Patrick Giguère Dr. Mario Tiberi ! Richard Leduc Dr. Yamina Berchiche Dr. Patrick Giguère Dr.
- GPCR Retreat Logo Contest | Dr. GPCR Ecosystem
Richard Leduc, will carefully evaluate each submission based on originality, visual appeal, conceptual
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Authors & Affiliations "Ana Lilia Moreno Salinas (2), Arturo Mancini (1), Raida Jallouli (2), Richard Leduc (2) (1)Domain Therapeutics North America Inc, Montréal, Québec, Canada (2) Department of Pharmacology-Physiology (2,3), Herthana Kandasamy (2), Sandra Morrissette (2), Arhamatoulaye Maiga (4), Michel Bouvier (4), Richard Leduc (1), Laurent Sabbagh (2) 1.
- Dr. Antony A. Boucard Jr | Dr. GPCR Ecosystem
Richard Leduc and Dr. Institut des Sciences, des Technologies et des Etudes Avancées d’Haïti (ISTEAH) to help consolidate higher education
- Dr. Richard Premont | Dr. GPCR Ecosystem
Richard Premont About Dr. Richard Premont "Dr. Richard Premont on the web Google Scholar LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast?
- Dr. Richard Premont | Dr. GPCR Ecosystem
Richard Premont About Dr. Richard Premont "Dr. Richard Premont on the web Google Scholar LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast?
- Dr. Richard Premont | Dr. GPCR Ecosystem
Richard Premont About Dr. Richard Premont "Dr. Richard Premont on the web Google Scholar LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast?
- Dr. Richard Premont | Dr. GPCR Ecosystem
Richard Premont About Dr. Richard Premont "Dr. Richard Premont on the web Google Scholar LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast?
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
Instructors at the course included Marc Chabre , Harden McConnell , Richard Henderson , Martin Rodbell This work involved active long-term collaborators, including Richard Mathies and Fritz Siebert , and
- Dr. Fiona Marshall | Dr. GPCR Ecosystem
Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.
- Dr. Caron Tribute Part 1 | Dr. GPCR Ecosystem
Richard Cerione (1985) Dr. Brian Kolbilka (1987) Dr. Frederik Leeb-Lundberg (1984) Dr.
- Dr. Caron Tribute Part 2 | Dr. GPCR Ecosystem
Richard Premont (1993) Dr. Jie Zhang (1990) Enjoying the Dr. GPCR Podcast? Leave a Review.
- Dr. Chris Tate | Dr. GPCR Ecosystem
obtaining a research fellowship at Girton College (Cambridge) he moved to the LMB in 1992 to work in Richard
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Disruption of these features reduced autoproteo-lytic activity in ADGRL1/LPHN1 and restored cleavage Authors & Affiliations "Garbett, Krassimira, Kordon, Szymon P., Shearer, Tanner, Sando, Richard C.*, interaction in the uncleaving ADGRB3 GAIN domain partially re-instates cleavage, while its deletion reduces
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
In medulloblastomas (MB), BAI3 (ADGRB3) expression is specifically reduced in the WNT-activated group WNT-MB cells will restrain ß-catenin activity through the formation of a BAI3/MAGI3/ß-catenin complex, reducing Attendees Authors & Affiliations " Hernández-Aranda Judith 2, Correoso-Braña Kerlys 1, Vialou Vincent 3, Leduc Richard 4, Olivares-Reyes Jesús Alberto 2, Boucard Antony A1. 1 Department of Cell Biology, Centro de
- Translating computational approaches to GPCR biologists with Dr. Riccardo Capelli | Dr. GPCR Ecosystem
Riccardo Capelli About Dr. Riccardo Capelli Dr. Riccardo Capelli is an assistant professor in Applied Physics at the Department of Biosciences, University Ricardo Capelli on the web Google Scholar ResearchGate Bysky App : @ riccardocapelli.bsky.social Twitter
- Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Dintzner1, 2, Leon Katherine1, 2, Dutka Przemysław1, Siffer Gracie3, Kossiakoff Anthony A.1, Sando Richard
- Class B GPCR drugs are reshaping treatment for migraine, diabetes, and obesity- but did you know ligand bias plays a key role in their success? This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock next-gen therapies. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com/reviews/where-are-we-now%3F-biased-signalling-of-class-b-g-protein-coupled-receptor-targeted-therapeutics #gpcr#drgpcr | Dr. GPCR Ecosystem
This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock This new review explores how tweaking peptide drugs can boost efficacy, reduce side effects, and unlock
- Did you know that GPR180 helps regulate lipid metabolism and may play a role in preventing obesity? recent study shows that overexpression of GPR180 in adipose tissue improves lipid metabolism and protects against HFD-induced obesity, while its knockout worsens lipid accumulation. This finding highlights GPR180 as a potential therapeutic target for metabolic disorders! Catch up on this exciting research in the Ecosystem today! 🏆📖 You’ll need to register, but don’t worry—it’s free! ➡️https://www.ecosystem.drgpcr.com/gpcrs-in-cardiology-endocrinology-and-taste/gpr180-reduces-adiposity-by-inhibiting-lipogenesis-and-fatty-acid-uptake-in-adipocytes #gpcr #drgpcr #metabolism #obesity | Dr. GPCR Ecosystem
➡️https://www.ecosystem.drgpcr.com/gpcrs-in-cardiology-endocrinology-and-taste/gpr180-reduces-adiposity-by-inhibiting-lipogenesis-and-fatty-acid-uptake-in-adipocytes ➡️ https:// www.ecosystem.drgpcr.com/gpcrs-in-cardiology-endocrinology-and-taste/gpr180-reduces-adiposity-by-inhibiting-lipogenesis-and-fatty-acid-uptake-in-adipocytes
- A new study from the Hudson Lab at the University of Glasgow shows that the FFA receptor antagonist AH7614 is actually an inverse agonist - suppressing fat cell formation, boosting lipolysis and reducing glucose uptake. Explore how targeting FFA4 could help fight metabolic disorders. Catch up with the latest research conducted in the Hudson lab in Ep. 161 of the Dr. GPCR Podcast. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com/gpcrs-in-cardiology-endocrinology-and-taste/inverse-agonism-of-the-ffa4-free-fatty-acid-receptor-controls-both-adipogenesis-and-mature-adipocyte-function #GPCR #drGPCR #FFA4 #metabolism #adipocytes” | Dr. GPCR Ecosystem
antagonist AH7614 is actually an inverse agonist - suppressing fat cell formation, boosting lipolysis and reducing antagonist AH7614 is actually an inverse agonist - suppressing fat cell formation, boosting lipolysis and reducing
- Donate to Dr GPCR — Support the GPCR Community & University
Your tax-deductible donation supports education, collaboration, and innovation. Your donation directly supports: Dr GPCR University : expanding and modernizing our educational programs Every donation fuels the mission to make GPCR education and collaboration more accessible to everyone with new lessons, updated materials, and interactive learning modules - $5,000+ 👉 Powers new GPCR educational
- Donation for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Help advance GPCR research, enable education, and connect the scientific community.
- About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery
researchers, industry, and partners to accelerate GPCR science and drug discovery—through connection, education Educate — Courses, talks, and curated content that turn expertise into execution.
- Dr GPCR Ecosystem Feedback | Dr. GPCR Ecosystem
By sharing your thoughts, you directly influence how we design new features, events, and educational This isn’t just a form — it’s how you influence the next generation of education, collaboration, and
- Weekly News October 23 | Dr. GPCR Ecosystem
candidates—or building models meant to predict, not narrate —this edition is built to shorten cycles and reduce
- CRO Advisory | Dr. GPCR Ecosystem
between technical teams and biotech clients • Set clear expectations and deliverables to build trust and reduce Translate discovery data into clear, actionable formats biotech teams can use • Streamline deliverables to reduce
- Complex Allosteric Cannabinoid Receptor Pharmacology
Robert was the President and Director of Education for the Canadian Consortium for the Investigation
- Robert Laprairie | Dr. GPCR Ecosystem
In 2019 he became the Director of Education for the Canadian Consortium for the Investigation of Cannabinoids
- Martin Audet | Dr. GPCR Ecosystem
Strong education with a Doctor of Philosophy (Ph.D.) in biochemistry under the supervision of Michel
- Dr. Terry Hébert | Dr. GPCR Ecosystem
Terry Hébert on the web Terry Hébert | Institute of Health Sciences Education Hébert Lab LinkedIn Hébert
















